Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.
Mifepristone medical abortion has been a valuable addition to the reproductive health options of women. Aspects of its provision have however sometimes limited its accessibility and use. This article summarizes existing evidence for simplifying the provision of medical abortion and thus increasing its availability. We identify three ways through which medical abortion provision might be simplified based on existing evidence and suggest five additional simplifications that require further research to confirm their safety and efficacy.
Clark
Wesley H
WH
Gynuity Health Projects, New York, NY 10010, USA. wclark@gynuity.org
Gold
Marji
M
Grossman
Daniel
D
Winikoff
Beverly
B
D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D009819:Office Visits; D011247:Pregnancy; D014463:Ultrasonography
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone